about
Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein MetabolismPharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol.Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetesNew Insights into the Regulation of Chylomicron Production.Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteinsInfluence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study.New and emerging regulators of intestinal lipoprotein secretion.Dietary carbohydrates and intestinal lipoprotein production.Intravenous Glucose Acutely Stimulates Intestinal Lipoprotein Secretion in Healthy Humans.High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men.Is Insulin Action in the Brain Relevant in Regulating Blood Glucose in Humans?Effects of GIK (glucose-insulin-potassium) on stress-induced myocardial ischaemia.Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans.Evaluation of the Effect of Enteral Lipid Sensing on Endogenous Glucose Production in Humans.Intranasal insulin suppresses endogenous glucose production in humans compared with placebo in the presence of similar venous insulin concentrations.
P50
Q27021060-42339DE8-DA69-4B7E-85AA-D1AEBFFE5BDBQ30249434-1E8C59DF-0366-4F85-B947-58DB34692608Q34355358-42D86DB6-189A-4496-99DA-D85528661D0AQ35227165-C8A08A98-90B0-45DC-8270-FCAD84B807C9Q35631859-7D610BB9-CFCE-4C5A-87F2-33C6E2F13087Q36763561-EDA7E10F-4DBD-4938-BE70-6BB880EA4E81Q37331224-BB607AAA-2AA6-41A6-BF0F-34DD6FF79AD5Q38188724-F34A7459-CFB2-4839-A35D-0DABAA04C0FAQ38206917-EB4B8006-8267-4340-955B-DD9F7939D0DDQ38392889-14BE337D-CAE3-4407-81B6-44B7FBEFA6D4Q38443882-C6BA7155-E9AE-42F0-B08E-E8940853146EQ38505836-B2F2FBDA-846E-4023-9DB7-82574BAF8A8EQ43225570-79F060CB-CA2F-451D-B69A-EA5E3B196543Q44009597-512EA5C6-6FF0-4E84-A6DE-B30BCD385C42Q48289135-2532C5BC-B4DA-4764-B466-663CA03ADED8Q48494600-0BEF3358-767A-4CE5-8251-19683387E550
P50
name
Cecilia Morgantini
@en
Cecilia Morgantini
@nl
type
label
Cecilia Morgantini
@en
Cecilia Morgantini
@nl
prefLabel
Cecilia Morgantini
@en
Cecilia Morgantini
@nl